Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs 4D Molecular Therapeutics, Inc. (FDMT)

DBV Technologies S.A. and 4D Molecular Therapeutics, Inc. are both Biotechnology companies. DBV Technologies S.A. and 4D Molecular Therapeutics, Inc. are of similar size ($621.5M and $615.8M). 4D Molecular Therapeutics, Inc. grew revenue faster over the last twelve months: 278,712.1% against −33.4%. 4D Molecular Therapeutics, Inc. has the higher net margin (−194.7% vs −5,547.3%) and the lower return on invested capital (−186.9% vs 0.00%). Across the 17 metrics below, 4D Molecular Therapeutics, Inc. leads on 14 and DBV Technologies S.A. on 3.

Valuation

Metric DBVT FDMT Biotechnology median
P/E n/m n/m 10.60
P/S 255.21 9.41 9.40
P/B 6.42 2.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 210.91 5.70 9.02
Earnings yield (29.23%) (22.38%) (32.88%)
Free cash flow yield (20.11%) (18.01%) (23.13%)

Profitability

Metric DBVT FDMT Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (5,571.63%) (214.24%) 0.00%
Net margin (5,547.30%) (194.74%) 0.00%
Free cash flow margin (5,131.50%) (169.51%) 0.00%
Return on equity (205.75%) (43.25%) (51.96%)
Return on assets (127.19%) (37.09%) (46.06%)
Return on invested capital 0.00% (186.91%) 0.00%

Growth

Metric DBVT FDMT Biotechnology median
Revenue growth (TTM) (33.42%) 278,712.12% 6.76%
EPS growth (last fiscal year) 10.26% 18.79% 29.88%
Revenue growth, 5-year CAGR (12.95%) 44.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT FDMT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 3.24 8.03 4.97
Net debt to EBITDA 1.35 2.52 1.01

Dividend

Metric DBVT FDMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DBVT FDMT Biotechnology median
Market cap 615.83m 621.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack